About Poly Medicure Limited
Data last updated: 13 July 2026
Poly Medicure Limited is a public limited company based in New Delhi, Delhi, India. It specialises in medical and laboratory equipment, a part of the broader healthcare sector. Incorporated on 30 March 1995, the company has been in operation for over 31 years.
Registered with ROC Delhi under CIN L40300DL1995PLC066923. Listed on BSE: 531768 and NSE: POLYMED.
Capital: an authorised share capital of ₹60 Cr and a paid-up capital of ₹50.68 Cr. Formerly known as Polymedicure Limited. It is led by directors including Alessandro Balboni and Ambrish Mithal.
Last AGM: 25 September 2025. Financial statements filed for year ended 31 March 2025. Office: Property No. – 232B Third Floor Okhla Industrial Estate Phase – Iii, New Delhi, Delhi, India – 110020.
As per NSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹1,875.26 Cr, a growth of 12.3% compared to the previous year. The net worth stands at ₹3,149.24 Cr (up 13.87% YoY). Total assets are valued at ₹3,918.57 Cr (up 22.74% YoY).
The company has a workforce of approximately 2,683 employees as per the latest available data.
The company is associated with 1 brand - Polymedicure. As per MCA filings, the company has open charges of ₹549.5 Cr and satisfied charges of ₹140.2 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website polymedicure.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressProperty No. – 232B Third Floor Okhla Industrial Estate Phase – Iii, New Delhi, Delhi, India – 110020
-
IndustryHealthcare, Medical & Laboratory Equipment
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Poly Medicure Limited
Poly Medicure Limited has one previous CIN (Corporate Identification Number): L74899DL1995PLC066923. The current CIN is L40300DL1995PLC066923, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L40300DL1995PLC066923 | Current |
| L74899DL1995PLC066923 | Previous |
Associated Brands with Poly Medicure Limited
Poly Medicure Limited operates one associated brand: Polymedicure. These brands represent Poly Medicure Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Medical devices for oncology, dialysis, and respiratory care are manufactured. | polymedicure.com |
Business Activity of Poly Medicure Limited
Poly Medicure Limited is engaged in the principal business activity of manufacturing, with detailed activities including plastic products, non-metallic mineral products, rubber products, fabricated metal products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C8 | Plastic products, non-metallic mineral products, rubber products, fabricated metal products | Locked |
Business activity turnover details for Poly Medicure Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Poly Medicure Limited
Poly Medicure Limited is audited by Doogar & Associates (ICAI peer reviewed, certificate valid till 2028-03-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| Doogar & Associates (ICAI peer reviewed, certificate valid till 2028-03-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Poly Medicure Limited
Poly Medicure Limited is currently managed by 12 directors, with 13 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Alessandro Balboni | Director | 10 May 2018 | 8 Years 3 Months | Current |
| Ambrish Mithal | Director | 04 Aug 2022 | 4 Years 0 Months | Current |
|
Devendra Raj Mehta
Also directs:
Agriglow Farmer Producer Company Limited, Atul Rajasthan Date Palms Limited, Gandhi Research Foundation and 2 more
|
Director | 26 May 2005 | 21 Years 2 Months | Current |
|
Rishi Baid
Also directs:
Plan1 Health India Private Limited, Zetta Matrix Consulting Llp
|
Whole-Time Director | 30 Mar 1995 | 31 Years 4 Months | Current |
| Himanshu Baid | Managing Director | 30 Mar 1995 | 31 Years 4 Months | Current |
| Amit Khosla | Director | 05 Jun 2020 | 6 Years 2 Months | Current |
Financials of Poly Medicure Limited FY 2026 filings available
Poly Medicure Limited reported revenue of ₹1,875.26 Cr (up 12.3% YoY) for FY 2026.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹1,875.26 Cr | ₹1,669.83 Cr | ₹1,375.8 Cr | ₹1,115.23 Cr | ₹923.06 Cr | ₹786.47 Cr | ₹687.24 Cr |
| Other Income | ₹120.08 Cr | ₹89.13 Cr | ₹58.75 Cr | ₹36.19 Cr | ₹37.9 Cr | ₹18.42 Cr | ₹18.46 Cr |
| Total Income | ₹1,995.34 Cr | ₹1,758.96 Cr | ₹1,434.54 Cr | ₹1,151.42 Cr | ₹960.97 Cr | ₹804.88 Cr | ₹705.7 Cr |
| Cost of Materials Consumed | ₹599.39 Cr | ₹571.36 Cr | ₹464.78 Cr | ₹424.31 Cr | ₹352.37 Cr | ₹266.58 Cr | ₹225.22 Cr |
| Purchases of Stock-in-Trade | ₹5.06 Cr | ₹7.94 Cr | ₹7.02 Cr | ₹5.21 Cr | ₹10.66 Cr | ₹3.08 Cr | ₹70.55 Lakh |
| Changes in Inventories | -₹7.64 Cr | -₹24.61 Cr | ₹10.8 Cr | -₹23.65 Cr | -₹14.95 Cr | -₹7.81 Cr | -₹8.88 Cr |
| Employee Benefit Expense | ₹402.26 Cr | ₹301.53 Cr | ₹245.91 Cr | ₹202.75 Cr | ₹163.62 Cr | ₹141.76 Cr | ₹138.76 Cr |
| Finance Costs | ₹18.29 Cr | ₹12 Cr | ₹11.3 Cr | ₹8.84 Cr | ₹4.25 Cr | ₹8.51 Cr | ₹18.31 Cr |
| Depreciation & Amortisation | ₹115.52 Cr | ₹82.64 Cr | ₹63.93 Cr | ₹57.17 Cr | ₹53.95 Cr | ₹47.52 Cr | ₹40.53 Cr |
| Other Expenses | ₹433.88 Cr | ₹360.77 Cr | ₹289.06 Cr | ₹241.22 Cr | ₹198.27 Cr | ₹168.49 Cr | ₹167.47 Cr |
| Total Expenses | ₹1,566.75 Cr | ₹1,311.62 Cr | ₹1,092.8 Cr | ₹915.85 Cr | ₹768.17 Cr | ₹628.14 Cr | ₹582.12 Cr |
| Profit Before Exceptional Items & Tax | ₹428.59 Cr | ₹447.34 Cr | ₹341.74 Cr | ₹235.56 Cr | ₹192.8 Cr | ₹176.74 Cr | ₹123.58 Cr |
| Exceptional Items | -₹6.8 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹421.79 Cr | ₹447.34 Cr | ₹341.74 Cr | ₹235.56 Cr | ₹192.8 Cr | ₹176.74 Cr | ₹123.58 Cr |
| Total Tax Expense | ₹106.74 Cr | ₹113.96 Cr | ₹86.01 Cr | ₹58.21 Cr | ₹48.74 Cr | ₹44.18 Cr | ₹29.85 Cr |
| Net Profit | ₹320.73 Cr | ₹338.56 Cr | ₹258.26 Cr | ₹179.28 Cr | ₹146.51 Cr | ₹135.87 Cr | ₹95.88 Cr |
| attributable to Owners | ₹322.14 Cr | ₹338.56 Cr | ₹258.26 Cr | ₹179.28 Cr | - | - | ₹0 |
| attributable to NCI | -₹1.41 Cr | ₹0 | ₹0 | ₹0 | - | - | ₹0 |
| Other Comprehensive Income | ₹46.49 Cr | -₹1.35 Cr | -₹88.36 Lakh | ₹40.61 Lakh | ₹23.71 Lakh | ₹10.46 Lakh | ₹28.58 Lakh |
| Total Comprehensive Income | ₹367.22 Cr | ₹337.2 Cr | ₹257.38 Cr | ₹179.69 Cr | ₹146.74 Cr | ₹135.98 Cr | ₹96.16 Cr |
| EBITDA (computed) | ₹562.4 Cr | ₹541.97 Cr | ₹416.97 Cr | ₹301.57 Cr | ₹251 Cr | ₹232.78 Cr | ₹182.42 Cr |
| Basic EPS | ₹31.79 | ₹34.13 | ₹26.92 | ₹18.69 | ₹15.28 | ₹15.25 | ₹10.86 |
| Diluted EPS | ₹31.75 | ₹34.11 | ₹26.90 | ₹18.67 | ₹15.27 | ₹15.24 | ₹10.86 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹3,918.57 Cr | ₹3,192.45 Cr | ₹1,858.67 Cr | ₹1,577.21 Cr |
| Non-current Assets | ₹1,976.83 Cr | ₹1,275.46 Cr | ₹1,017.05 Cr | ₹770.2 Cr |
| Current Assets | ₹1,941.73 Cr | ₹1,917 Cr | ₹841.63 Cr | ₹807.01 Cr |
| Property, Plant & Equipment | ₹1,255.15 Cr | ₹1,038.14 Cr | ₹818.53 Cr | ₹587.32 Cr |
| Inventories | ₹433.84 Cr | ₹285.57 Cr | ₹221.03 Cr | ₹208.65 Cr |
| Trade Receivables | ₹531.17 Cr | ₹349.73 Cr | ₹269.94 Cr | ₹235.43 Cr |
| Cash & Equivalents | ₹51.23 Cr | ₹8.7 Cr | ₹12.05 Cr | ₹7.06 Cr |
| Equity (Net Worth) | ₹3,149.24 Cr | ₹2,765.66 Cr | ₹1,470.05 Cr | ₹1,241.63 Cr |
| Equity Share Capital | ₹50.68 Cr | ₹50.66 Cr | ₹47.99 Cr | ₹47.97 Cr |
| Borrowings (Non-current) | ₹52.09 Cr | ₹0 | ₹1.09 Cr | ₹17.5 Cr |
| Borrowings (Current) | ₹289.53 Cr | ₹177.65 Cr | ₹169.13 Cr | ₹128.93 Cr |
| Total Debt (computed) | ₹341.62 Cr | ₹177.65 Cr | ₹170.21 Cr | ₹146.43 Cr |
| Current Liabilities | ₹575.52 Cr | ₹370.17 Cr | ₹351.24 Cr | ₹293.3 Cr |
| Total Liabilities | ₹769.32 Cr | ₹426.79 Cr | ₹388.62 Cr | ₹335.58 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹240.69 Cr | ₹241.09 Cr | ₹266.08 Cr | ₹190.83 Cr | ₹123.47 Cr |
| Investing Cash Flow | -₹225.38 Cr | -₹1,191.17 Cr | -₹240.94 Cr | -₹179.02 Cr | -₹85.33 Cr |
| Financing Cash Flow | ₹20.15 Cr | ₹952.93 Cr | -₹20.15 Cr | -₹12.51 Cr | -₹35.34 Cr |
| Capital Expenditure | ₹308.39 Cr | ₹324.99 Cr | ₹277.02 Cr | ₹239.27 Cr | ₹155.58 Cr |
| Free Cash Flow (computed) | -₹67.7 Cr | -₹83.9 Cr | -₹10.93 Cr | -₹48.45 Cr | -₹32.11 Cr |
| Dividends Paid | ₹35.43 Cr | ₹30.34 Cr | ₹28.74 Cr | ₹23.97 Cr | ₹23.92 Cr |
| Net Change in Cash | ₹36.85 Cr | ₹2.85 Cr | ₹4.99 Cr | -₹69.5 Lakh | ₹2.8 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹534.51 Cr | ₹493.66 Cr | ₹443.88 Cr | ₹403.21 Cr | ₹440.83 Cr | ₹424.21 Cr | ₹420.02 Cr | ₹384.78 Cr | ₹378.07 Cr | ₹339.6 Cr | ₹337.29 Cr | ₹320.83 Cr |
| Other Income | ₹17.76 Cr | ₹26.26 Cr | ₹33.94 Cr | ₹41.69 Cr | ₹24.31 Cr | ₹21.8 Cr | ₹26.1 Cr | ₹16.92 Cr | ₹14.97 Cr | ₹16.57 Cr | ₹14.09 Cr | ₹13.11 Cr |
| Total Income | ₹552.27 Cr | ₹519.92 Cr | ₹477.83 Cr | ₹444.9 Cr | ₹465.14 Cr | ₹446.01 Cr | ₹446.11 Cr | ₹401.7 Cr | ₹393.05 Cr | ₹356.17 Cr | ₹351.39 Cr | ₹333.94 Cr |
| Cost of Materials Consumed | ₹155.08 Cr | ₹146.17 Cr | ₹157.07 Cr | ₹141.07 Cr | ₹141.95 Cr | ₹141.95 Cr | ₹154.88 Cr | ₹132.57 Cr | ₹126.61 Cr | ₹118.72 Cr | ₹114.21 Cr | ₹105.25 Cr |
| Purchases of Stock-in-Trade | ₹1.38 Cr | ₹1.58 Cr | ₹1.23 Cr | ₹85.85 Lakh | ₹2.51 Cr | ₹3.32 Cr | ₹1.21 Cr | ₹89.26 Lakh | ₹1.35 Cr | ₹1.05 Cr | ₹2.85 Cr | ₹1.77 Cr |
| Changes in Inventories | ₹21.7 Cr | ₹8.01 Cr | -₹22.65 Cr | -₹14.7 Cr | ₹2.93 Cr | ₹1.23 Cr | -₹23.57 Cr | -₹5.2 Cr | ₹3.24 Cr | -₹1.73 Cr | ₹4.16 Cr | ₹5.14 Cr |
| Employee Benefit Expense | ₹126.14 Cr | ₹115.2 Cr | ₹88.83 Cr | ₹75.11 Cr | ₹78.89 Cr | ₹77.89 Cr | ₹78.09 Cr | ₹70.79 Cr | ₹69.44 Cr | ₹60.4 Cr | ₹58.32 Cr | ₹57.75 Cr |
| Finance Costs | ₹6.41 Cr | ₹5.96 Cr | ₹2.97 Cr | ₹2.95 Cr | ₹2.17 Cr | ₹3.33 Cr | ₹3.34 Cr | ₹3.16 Cr | ₹3.12 Cr | ₹3.47 Cr | ₹2.22 Cr | ₹2.49 Cr |
| Depreciation & Amortisation | ₹38.23 Cr | ₹28.76 Cr | ₹24.93 Cr | ₹23.26 Cr | ₹21.03 Cr | ₹21.51 Cr | ₹20.85 Cr | ₹19.65 Cr | ₹16.2 Cr | ₹16.21 Cr | ₹15.99 Cr | ₹15.52 Cr |
| Other Expenses | ₹119.81 Cr | ₹111.51 Cr | ₹104.71 Cr | ₹94.73 Cr | ₹95.08 Cr | ₹85.26 Cr | ₹94.08 Cr | ₹81.81 Cr | ₹80.85 Cr | ₹70.93 Cr | ₹73.54 Cr | ₹63.74 Cr |
| Total Expenses | ₹468.75 Cr | ₹417.19 Cr | ₹357.1 Cr | ₹323.28 Cr | ₹344.56 Cr | ₹334.51 Cr | ₹328.88 Cr | ₹303.67 Cr | ₹300.82 Cr | ₹269.05 Cr | ₹271.27 Cr | ₹251.65 Cr |
| Profit Before Exceptional Items & Tax | ₹83.51 Cr | ₹102.73 Cr | ₹120.73 Cr | ₹121.62 Cr | ₹120.57 Cr | ₹111.51 Cr | ₹117.23 Cr | ₹98.02 Cr | ₹92.23 Cr | ₹87.11 Cr | ₹80.11 Cr | ₹82.29 Cr |
| Exceptional Items | ₹0 | -₹6.8 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹74.9 Lakh |
| Profit Before Tax | ₹83.51 Cr | ₹95.93 Cr | ₹120.73 Cr | ₹121.62 Cr | ₹120.57 Cr | ₹111.51 Cr | ₹117.23 Cr | ₹98.02 Cr | ₹92.23 Cr | ₹87.11 Cr | ₹80.11 Cr | ₹83.04 Cr |
| Total Tax Expense | ₹20.18 Cr | ₹26.8 Cr | ₹29.89 Cr | ₹29.86 Cr | ₹31.02 Cr | ₹28 Cr | ₹30.53 Cr | ₹24.42 Cr | ₹24.1 Cr | ₹22.81 Cr | ₹18.76 Cr | ₹20.35 Cr |
| Net Profit | ₹65.04 Cr | ₹70.81 Cr | ₹91.8 Cr | ₹93.08 Cr | ₹91.83 Cr | ₹85.23 Cr | ₹87.45 Cr | ₹74.04 Cr | ₹68.36 Cr | ₹65.02 Cr | ₹62.19 Cr | ₹62.7 Cr |
| attributable to Owners | ₹66.29 Cr | ₹70.93 Cr | ₹91.84 Cr | ₹93.08 Cr | ₹91.83 Cr | ₹85.23 Cr | ₹87.45 Cr | ₹74.04 Cr | ₹68.36 Cr | ₹65.02 Cr | ₹62.19 Cr | ₹62.7 Cr |
| attributable to NCI | -₹1.25 Cr | -₹12.13 Lakh | -₹3.75 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | - |
| Other Comprehensive Income | ₹24.9 Cr | ₹22.52 Cr | -₹24.39 Lakh | -₹68.72 Lakh | ₹14.11 Lakh | -₹20.08 Lakh | ₹8.09 Lakh | -₹1.38 Cr | -₹8.41 Lakh | ₹24.65 Lakh | -₹80.71 Lakh | -₹23.89 Lakh |
| Total Comprehensive Income | ₹89.94 Cr | ₹93.33 Cr | ₹91.55 Cr | ₹92.4 Cr | ₹91.98 Cr | ₹85.03 Cr | ₹87.54 Cr | ₹72.66 Cr | ₹68.27 Cr | ₹65.26 Cr | ₹61.38 Cr | ₹62.46 Cr |
| EBITDA (computed) | ₹128.15 Cr | ₹137.45 Cr | ₹148.63 Cr | ₹147.83 Cr | ₹143.77 Cr | ₹136.34 Cr | ₹141.43 Cr | ₹120.84 Cr | ₹111.55 Cr | ₹106.79 Cr | ₹98.32 Cr | ₹100.31 Cr |
| Basic EPS | ₹6.54 | ₹7.00 | ₹9.06 | ₹9.19 | ₹8.92 | ₹8.48 | ₹9.01 | ₹7.71 | ₹7.12 | ₹6.78 | ₹6.48 | ₹6.54 |
| Diluted EPS | ₹6.53 | ₹6.99 | ₹9.06 | ₹9.17 | ₹8.92 | ₹8.48 | ₹9.01 | ₹7.71 | ₹7.12 | ₹6.77 | ₹6.47 | ₹6.53 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹1,662.46 Cr | ₹1,601.8 Cr | ₹1,307.25 Cr | ₹1,068.05 Cr | ₹879.36 Cr | ₹747.38 Cr | ₹646.16 Cr |
| Other Income | ₹119.92 Cr | ₹89.77 Cr | ₹58.18 Cr | ₹36.29 Cr | ₹38.73 Cr | ₹19.29 Cr | ₹18.58 Cr |
| Total Income | ₹1,782.38 Cr | ₹1,691.57 Cr | ₹1,365.43 Cr | ₹1,104.33 Cr | ₹918.09 Cr | ₹766.67 Cr | ₹664.75 Cr |
| Cost of Materials Consumed | ₹538.86 Cr | ₹540.88 Cr | ₹432.77 Cr | ₹394.84 Cr | ₹331.28 Cr | ₹245.91 Cr | ₹207.01 Cr |
| Purchases of Stock-in-Trade | ₹5.04 Cr | ₹7.93 Cr | ₹7.02 Cr | ₹5.21 Cr | ₹10.66 Cr | ₹3.08 Cr | ₹70.55 Lakh |
| Changes in Inventories | -₹13.4 Cr | -₹17.04 Cr | ₹13.02 Cr | -₹15.52 Cr | -₹14.1 Cr | -₹2.24 Cr | -₹7.77 Cr |
| Employee Benefit Expense | ₹313.15 Cr | ₹280.08 Cr | ₹228.85 Cr | ₹188.35 Cr | ₹149.89 Cr | ₹130.74 Cr | ₹127.34 Cr |
| Finance Costs | ₹13.43 Cr | ₹11.41 Cr | ₹10.74 Cr | ₹8.3 Cr | ₹3.61 Cr | ₹7.91 Cr | ₹17.66 Cr |
| Depreciation & Amortisation | ₹97.9 Cr | ₹80.84 Cr | ₹62.05 Cr | ₹55.64 Cr | ₹52.54 Cr | ₹46.31 Cr | ₹39.28 Cr |
| Other Expenses | ₹372.71 Cr | ₹344.58 Cr | ₹276.07 Cr | ₹230.68 Cr | ₹189.49 Cr | ₹161.56 Cr | ₹158.74 Cr |
| Total Expenses | ₹1,327.69 Cr | ₹1,248.68 Cr | ₹1,030.53 Cr | ₹867.51 Cr | ₹723.37 Cr | ₹593.29 Cr | ₹542.96 Cr |
| Profit Before Exceptional Items & Tax | ₹454.7 Cr | ₹442.89 Cr | ₹334.89 Cr | ₹236.83 Cr | ₹194.72 Cr | ₹173.38 Cr | ₹121.78 Cr |
| Exceptional Items | -₹6.8 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹447.89 Cr | ₹442.89 Cr | ₹334.89 Cr | ₹236.83 Cr | ₹194.72 Cr | ₹173.38 Cr | ₹121.78 Cr |
| Total Tax Expense | ₹111.91 Cr | ₹111.56 Cr | ₹83.17 Cr | ₹57.78 Cr | ₹48.7 Cr | ₹43.87 Cr | ₹29.4 Cr |
| Net Profit | ₹335.98 Cr | ₹331.33 Cr | ₹251.72 Cr | ₹179.04 Cr | ₹146.02 Cr | ₹129.51 Cr | ₹92.38 Cr |
| Other Comprehensive Income | ₹22.62 Lakh | -₹1.55 Cr | -₹84.52 Lakh | ₹14.82 Lakh | ₹23.71 Lakh | ₹10.46 Lakh | ₹28.58 Lakh |
| Total Comprehensive Income | ₹336.21 Cr | ₹329.79 Cr | ₹250.88 Cr | ₹179.19 Cr | ₹146.25 Cr | ₹129.62 Cr | ₹92.67 Cr |
| EBITDA (computed) | ₹566.03 Cr | ₹535.14 Cr | ₹407.69 Cr | ₹300.76 Cr | ₹250.86 Cr | ₹227.61 Cr | ₹178.72 Cr |
| Basic EPS | ₹33.15 | ₹33.40 | ₹26.24 | ₹18.67 | ₹15.23 | ₹14.54 | ₹10.47 |
| Diluted EPS | ₹33.12 | ₹33.39 | ₹26.22 | ₹18.65 | ₹15.22 | ₹14.53 | ₹10.46 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹3,549.95 Cr | ₹3,140.36 Cr | ₹1,821.35 Cr | ₹1,537.76 Cr |
| Non-current Assets | ₹1,910.38 Cr | ₹1,280.02 Cr | ₹1,029.57 Cr | ₹782.18 Cr |
| Current Assets | ₹1,639.57 Cr | ₹1,860.34 Cr | ₹791.78 Cr | ₹755.58 Cr |
| Property, Plant & Equipment | ₹1,200.19 Cr | ₹1,030.24 Cr | ₹811.83 Cr | ₹580.12 Cr |
| Inventories | ₹281.34 Cr | ₹249.87 Cr | ₹193.01 Cr | ₹182.8 Cr |
| Trade Receivables | ₹442.25 Cr | ₹340.09 Cr | ₹259.28 Cr | ₹221.02 Cr |
| Cash & Equivalents | ₹5.94 Cr | ₹54.85 Lakh | ₹2.14 Cr | ₹38.28 Lakh |
| Equity (Net Worth) | ₹3,052.71 Cr | ₹2,744.22 Cr | ₹1,458.25 Cr | ₹1,234.12 Cr |
| Equity Share Capital | ₹50.68 Cr | ₹50.66 Cr | ₹47.99 Cr | ₹47.97 Cr |
| Borrowings (Non-current) | ₹2.53 Cr | ₹0 | ₹1.09 Cr | ₹11.56 Cr |
| Borrowings (Current) | ₹245.9 Cr | ₹169.86 Cr | ₹159.49 Cr | ₹122.96 Cr |
| Total Debt (computed) | ₹248.43 Cr | ₹169.86 Cr | ₹160.58 Cr | ₹134.51 Cr |
| Current Liabilities | ₹419.27 Cr | ₹341.8 Cr | ₹327.53 Cr | ₹268.95 Cr |
| Total Liabilities | ₹497.24 Cr | ₹396.14 Cr | ₹363.1 Cr | ₹303.64 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹245.2 Cr | ₹236.65 Cr | ₹256.1 Cr | ₹194.86 Cr | ₹126.26 Cr |
| Investing Cash Flow | -₹267.84 Cr | -₹1,191.17 Cr | -₹237.02 Cr | -₹187.22 Cr | -₹88.71 Cr |
| Financing Cash Flow | ₹28.03 Cr | ₹952.93 Cr | -₹17.32 Cr | -₹7.89 Cr | -₹39.71 Cr |
| Capital Expenditure | ₹295.51 Cr | ₹324.99 Cr | ₹271.39 Cr | ₹237.46 Cr | ₹151.8 Cr |
| Free Cash Flow (computed) | -₹50.31 Cr | -₹88.34 Cr | -₹15.29 Cr | -₹42.6 Cr | -₹25.54 Cr |
| Dividends Paid | ₹35.43 Cr | ₹30.34 Cr | ₹28.74 Cr | ₹23.97 Cr | ₹23.92 Cr |
| Net Change in Cash | ₹5.39 Cr | -₹1.59 Cr | ₹1.76 Cr | -₹25.06 Lakh | -₹2.16 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹443.01 Cr | ₹418.86 Cr | ₹416.54 Cr | ₹384.05 Cr | ₹420.97 Cr | ₹410.94 Cr | ₹402.47 Cr | ₹367.42 Cr | ₹360.93 Cr | ₹320.86 Cr | ₹319.9 Cr | ₹305.56 Cr |
| Other Income | ₹15.12 Cr | ₹29.55 Cr | ₹33.72 Cr | ₹41.1 Cr | ₹23.95 Cr | ₹21.75 Cr | ₹27.24 Cr | ₹16.83 Cr | ₹15.66 Cr | ₹16.56 Cr | ₹12.78 Cr | ₹13.17 Cr |
| Total Income | ₹458.14 Cr | ₹448.41 Cr | ₹450.26 Cr | ₹425.14 Cr | ₹444.92 Cr | ₹432.68 Cr | ₹429.71 Cr | ₹384.26 Cr | ₹376.59 Cr | ₹337.43 Cr | ₹332.68 Cr | ₹318.73 Cr |
| Cost of Materials Consumed | ₹136.96 Cr | ₹128.82 Cr | ₹144.32 Cr | ₹128.75 Cr | ₹135.12 Cr | ₹135.43 Cr | ₹145.02 Cr | ₹125.3 Cr | ₹117.03 Cr | ₹111.46 Cr | ₹104.88 Cr | ₹99.4 Cr |
| Purchases of Stock-in-Trade | ₹1.36 Cr | ₹1.58 Cr | ₹1.23 Cr | ₹85.85 Lakh | ₹2.51 Cr | ₹3.32 Cr | ₹1.21 Cr | ₹89.26 Lakh | ₹1.35 Cr | ₹1.05 Cr | ₹2.85 Cr | ₹1.77 Cr |
| Changes in Inventories | ₹9.53 Cr | ₹4.09 Cr | -₹19.46 Cr | -₹7.55 Cr | ₹6.28 Cr | ₹1.48 Cr | -₹19.69 Cr | -₹5.11 Cr | ₹5.69 Cr | -₹1.49 Cr | ₹5.37 Cr | ₹3.47 Cr |
| Employee Benefit Expense | ₹78.1 Cr | ₹85.24 Cr | ₹82.9 Cr | ₹69.93 Cr | ₹71.98 Cr | ₹72.79 Cr | ₹73.04 Cr | ₹66.4 Cr | ₹62.29 Cr | ₹57.06 Cr | ₹55.1 Cr | ₹54.41 Cr |
| Finance Costs | ₹3.89 Cr | ₹3.94 Cr | ₹2.78 Cr | ₹2.81 Cr | ₹2.17 Cr | ₹3.13 Cr | ₹3.13 Cr | ₹2.98 Cr | ₹2.93 Cr | ₹3.35 Cr | ₹2.1 Cr | ₹2.36 Cr |
| Depreciation & Amortisation | ₹25.51 Cr | ₹25.06 Cr | ₹24.15 Cr | ₹22.84 Cr | ₹21.33 Cr | ₹20.83 Cr | ₹20.11 Cr | ₹18.98 Cr | ₹16.16 Cr | ₹15.53 Cr | ₹15.33 Cr | ₹15.04 Cr |
| Other Expenses | ₹95.97 Cr | ₹86.86 Cr | ₹96.33 Cr | ₹90.44 Cr | ₹89.03 Cr | ₹82.31 Cr | ₹89.96 Cr | ₹78.74 Cr | ₹77.16 Cr | ₹68.39 Cr | ₹69.11 Cr | ₹61.42 Cr |
| Total Expenses | ₹351.33 Cr | ₹335.59 Cr | ₹332.26 Cr | ₹308.08 Cr | ₹328.42 Cr | ₹319.3 Cr | ₹312.78 Cr | ₹288.18 Cr | ₹282.62 Cr | ₹255.34 Cr | ₹254.72 Cr | ₹237.86 Cr |
| Profit Before Exceptional Items & Tax | ₹106.81 Cr | ₹112.82 Cr | ₹118.01 Cr | ₹117.06 Cr | ₹116.5 Cr | ₹113.39 Cr | ₹116.93 Cr | ₹96.08 Cr | ₹93.97 Cr | ₹82.09 Cr | ₹77.96 Cr | ₹80.87 Cr |
| Exceptional Items | ₹0 | -₹6.8 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹106.81 Cr | ₹106.01 Cr | ₹118.01 Cr | ₹117.06 Cr | ₹116.5 Cr | ₹113.39 Cr | ₹116.93 Cr | ₹96.08 Cr | ₹93.97 Cr | ₹82.09 Cr | ₹77.96 Cr | ₹80.87 Cr |
| Total Tax Expense | ₹26.18 Cr | ₹27.63 Cr | ₹28.96 Cr | ₹29.14 Cr | ₹29.84 Cr | ₹28.24 Cr | ₹29.71 Cr | ₹23.77 Cr | ₹23.44 Cr | ₹20.63 Cr | ₹18.76 Cr | ₹20.34 Cr |
| Net Profit | ₹80.62 Cr | ₹78.38 Cr | ₹89.05 Cr | ₹87.93 Cr | ₹86.66 Cr | ₹85.15 Cr | ₹87.22 Cr | ₹72.3 Cr | ₹70.53 Cr | ₹61.46 Cr | ₹59.21 Cr | ₹60.52 Cr |
| Other Comprehensive Income | ₹62.83 Lakh | ₹22.39 Lakh | ₹25.18 Lakh | -₹87.79 Lakh | -₹3.96 Lakh | ₹14.97 Lakh | -₹36.5 Lakh | -₹1.29 Cr | -₹12,000 | ₹4.96 Lakh | -₹79.97 Lakh | -₹9.39 Lakh |
| Total Comprehensive Income | ₹81.25 Cr | ₹78.61 Cr | ₹89.3 Cr | ₹87.05 Cr | ₹86.62 Cr | ₹85.3 Cr | ₹86.86 Cr | ₹71.01 Cr | ₹70.53 Cr | ₹61.51 Cr | ₹58.41 Cr | ₹60.43 Cr |
| EBITDA (computed) | ₹136.21 Cr | ₹141.82 Cr | ₹144.94 Cr | ₹142.72 Cr | ₹139.99 Cr | ₹137.35 Cr | ₹140.17 Cr | ₹118.03 Cr | ₹113.06 Cr | ₹100.97 Cr | ₹95.39 Cr | ₹98.27 Cr |
| Basic EPS | ₹7.95 | ₹7.73 | ₹8.79 | ₹8.68 | ₹8.40 | ₹8.48 | ₹8.99 | ₹7.53 | ₹7.35 | ₹6.41 | ₹6.17 | ₹6.31 |
| Diluted EPS | ₹7.95 | ₹7.72 | ₹8.78 | ₹8.67 | ₹8.40 | ₹8.48 | ₹8.98 | ₹7.53 | ₹7.35 | ₹6.40 | ₹6.17 | ₹6.30 |
Shareholding Pattern of Poly Medicure Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 62.42%, foreign institutional investors hold 5.91%, domestic institutional investors hold 15.59%, retail and other public shareholders hold 16.08% of Poly Medicure Limited. The company had 73,414 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 62.42% | 62.42% | 62.42% | 62.44% | 62.44% | 62.44% |
| Public | 37.58% | 37.58% | 37.58% | 37.56% | 37.56% | 37.56% |
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 62.42% | 62.44% | 53.15% | 53.31% | 44.66% | 44.88% | 48.76% | 48.75% | 48.76% | 48.76% | 48.76% |
| Public | 37.58% | 37.56% | 46.85% | 46.69% | 55.34% | 55.12% | 51.24% | 51.25% | 51.24% | 51.24% | 51.24% |
| Promoter change (YoY, %pts) | -0.02 | +9.29 | -0.16 | +8.65 | -0.22 | -3.88 | +0.01 | -0.01 | +0.00 | +0.00 | - |
Board & Governance of Poly Medicure Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Poly Medicure Limited has 12 directors - 5 independent and 4 executive. The board is chaired by DEVENDRA RAJ MEHTA.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| DEVENDRA RAJ MEHTA | Non-Executive - Non Independent Director · Chairperson | 2014-09-23 | 1 |
| HIMANSHU BAID | Executive Director · MD | 1995-04-01 | 3 |
| RISHI BAID | Executive Director | 1995-04-01 | 1 |
| JUGAL KISHORE BAID | Non-Executive - Non Independent Director | 1995-05-20 | 1 |
| ALESSANDRO BALBONI | Non-Executive - Non Independent Director | 2018-05-10 | 1 |
| AMIT KHOSLA | Non-Executive - Independent Director | 2020-06-05 | 1 |
| SONAL MATTOO | Non-Executive - Independent Director | 2020-08-29 | 1 |
| AMBRISH MITHAL | Non-Executive - Independent Director | 2022-08-04 | 1 |
| VIMAL BHANDARI | Non-Executive - Independent Director | 2024-07-22 | 4 |
| VISHAL GUPTA | Non-Executive - Independent Director | 2024-10-28 | 2 |
| VISHAL BAID | Executive Director | 2025-05-06 | 1 |
| PANKAJ KUMAR GUPTA | Executive Director | 2025-08-08 | 1 |
| Committee | Members |
|---|---|
| Audit Committee | AMIT KHOSLA (Chairperson), DEVENDRA RAJ MEHTA, VIMAL BHANDARI |
| Nomination and remuneration committee | SONAL MATTOO (Chairperson), DEVENDRA RAJ MEHTA, AMIT KHOSLA |
| Stakeholders Relationship Committee | AMIT KHOSLA (Chairperson), HIMANSHU BAID, RISHI BAID, VISHAL GUPTA |
| Risk Management Committee | SONAL MATTOO (Chairperson), RISHI BAID, HIMANSHU BAID, VIMAL BHANDARI |
| Corporate Social Responsibility Committee | DEVENDRA RAJ MEHTA (Chairperson), JUGAL KISHORE BAID, SONAL MATTOO |
Charges & Borrowings of Poly Medicure Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Apr 2026 | Hdfc Bank Limited | ₹70 Cr | Open |
| 18 Apr 2025 | Hdfc Bank Limited | ₹30 Cr | Open |
| 07 Nov 2017 | Hdfc Bank Limited | ₹12.5 Cr | Open |
| 14 Feb 2017 | The Hongkong and Shanghai Banking Corporation Limited | ₹10 Cr | Open |
| 15 Jun 2011 | Citi Bank N.A. | ₹25 Cr | Open |
Total charge records: 11 View all charges
Employees and EPFO Compliance at Poly Medicure Limited
Poly Medicure Limited has a workforce of 2,683 employees as of Apr 05, 2024.
Employee and EPFO history for Poly Medicure Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Poly Medicure Limited
GST registrations and filing compliance for Poly Medicure Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Poly Medicure Limited
Credit ratings, litigation, and regulatory alerts for Poly Medicure Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Poly Medicure Limited
MSME payment history for Poly Medicure Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Poly Medicure Limited
Corporate group structure for Poly Medicure Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Poly Medicure Limited
MCA filings and documents for Poly Medicure Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Poly Medicure Limited
Recent News on Poly Medicure Limited
Frequently Asked Questions about Poly Medicure Limited
Poly Medicure Limited is an active public limited company in the healthcare sector based in New Delhi, Delhi, India. It was incorporated on 30 March 1995 (31+ years old) and is registered under CIN L40300DL1995PLC066923. Listed on BSE: 531768 and NSE: POLYMED. The company has 2,683 employees.
Poly Medicure Limited reported revenue of ₹1,875.26 Cr for FY 2026 (up 12.3% YoY) based on consolidated NSE filings.
The current directors of Poly Medicure Limited are:
- Alessandro Balboni - Director
- Ambrish Mithal - Director
- Devendra Raj Mehta - Director
- Rishi Baid - Whole-Time Director
- Himanshu Baid - Managing Director
- Amit Khosla - Director
- Sonal Mattoo - Director
- Jugal Kishore Baid - Director
- Pankaj Kumar Gupta - Whole-Time Director
- Vishal Baid - Director
- Vishal Gupta - Director
- Vimal Bhandari - Director
The primary industry of Poly Medicure Limited is healthcare. The company specifically operates in medical and laboratory equipment. The company is currently active in this sector.
Yes. Poly Medicure Limited is listed on both BSE (code: 531768) and NSE (symbol: POLYMED).
Poly Medicure Limited can be reached at the registered office: Property No. – 232B Third Floor Okhla Industrial Estate Phase – Iii, New Delhi, Delhi, India – 110020, or through the website polymedicure.com.